The Patent Finder

Biomira, Inc.

Also on record
Records under this name other than patents Biomira, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Biomira, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,491,707Synthetic lipid-a-analogs and uses thereof
Formerly held
Term ended
Term ended Nov 15, 2020 · USPTO record
Term endedTerm ended Nov 15, 2020USPTO record
US 8,198,400Vaccine for modulating between T1 and T2 immune responses
Formerly held
Lapsed on the fee record
Ended Jun 12, 2020 · USPTO record
Lapsed on the fee recordEnded Jun 12, 2020USPTO record
US 8,097,593Lipid A and other carbohydrate ligand analogs
Formerly held
Lapsed on the fee record
Ended Jan 17, 2020 · USPTO record
Lapsed on the fee recordEnded Jan 17, 2020USPTO record
US 9,173,929Mucinous glycoprotein (MUC-1) vaccine
Formerly held
Lapsed on the fee record
Ended Nov 3, 2019 · USPTO record
Lapsed on the fee recordEnded Nov 3, 2019USPTO record
US 6,544,549Multilamellar coalescence vesicles (MLCV) containing biologically active compounds
Formerly held
Term ended
Term ended Sep 25, 2019 · USPTO record
Term endedTerm ended Sep 25, 2019USPTO record
US 8,871,250Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine
Lapsed on the fee record
Ended Oct 28, 2018 · USPTO record
Lapsed on the fee recordEnded Oct 28, 2018USPTO record
US 6,312,718Vaccine for B-cell malignancies
Formerly held
Term ended
Term ended Oct 27, 2018 · USPTO record
Term endedTerm ended Oct 27, 2018USPTO record
US 7,820,627Lipid A and other carbohydrate ligand analogs
Formerly held
Lapsed on the fee record
Ended Oct 26, 2018 · USPTO record
Lapsed on the fee recordEnded Oct 26, 2018USPTO record
US 7,741,297Immunostimulatory, covalently lipidated oligonucleotides
Formerly held
Lapsed on the fee record
Ended Jun 22, 2018 · USPTO record
Lapsed on the fee recordEnded Jun 22, 2018USPTO record
US 6,600,012Lipid-modified muc-1 derivatives
Formerly held
Term ended
Term ended May 8, 2018 · USPTO record
Term endedTerm ended May 8, 2018USPTO record
10 of 30 patents shown.
Pro members see all 30.
Pro members: see all 30 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited